Similar articles

• Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!

  Boudjelal M, Nehdi A, Islam I. Boudjelal M, et al. Expert Opin Drug Discov. 2020 Nov;15(11):1233-1235. doi: 10.1080/17460441.2020.1777980. Epub 2020 Jun 16. Expert Opin Drug Discov. 2020. PMID: 32543297 No abstract available.
• Commercial influence and covid-19.

  Moynihan R, Macdonald H, Bero L, Godlee F. Moynihan R, et al. BMJ. 2020 Jun 24;369:m2456. doi: 10.1136/bmj.m2456. BMJ. 2020. PMID: 32580930 No abstract available.
• Ärzte können auf Finanzhilfe hoffen : COVID-19-Pandemie.

  Springer Medizin. Springer Medizin. MMW Fortschr Med. 2020 May;162(9):33-34. doi: 10.1007/s15006-020-0469-9. MMW Fortschr Med. 2020. PMID: 32405847 Free PMC article. German. No abstract available.
• The further evolution of biotech.

  Nagle T, Berg C, Nassr R, Pang K. Nagle T, et al. Nat Rev Drug Discov. 2003 Jan;2(1):75-9. doi: 10.1038/nrd989. Nat Rev Drug Discov. 2003. PMID: 12509762 Review.
• Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.

  Polansky H, Lori G. Polansky H, et al. J Evid Based Integr Med. 2020 Jan-Dec;25:2515690X20932523. doi: 10.1177/2515690X20932523. J Evid Based Integr Med. 2020. PMID: 32551855 Free PMC article. Review.